Literature DB >> 12889519

Increased cardiac weight in interleukin-6 transgenic mice with viral infection accompanies impaired expression of natriuretic peptide genes.

T Tanaka1, T Kanda, T Itoh, H Tsugawa, N Takekoshi, J Yamakawa, M Kurimoto, M Kurabayashi.   

Abstract

Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) regulate cardiac hypertrophy. We investigated ventricular alterations of ANP and BNP in interleukin-6 (IL-6) transgenic mice (TG) and wild type (WT) mice with or without viral infection. The ANP and BNP mRNA/GAPDH mRNA ratios in the ventricles of IL-6 TG mice were twice that of WT mice, but were not increased significantly by viral inoculation. In WT mice, both ANP and BNP responses were significantly increased in the ventricles of mice 10 days after encephalomyocarditis (EMC) viral inoculation. Cardiac weight in IL-6 TG mice was significantly greater than in WT 10 days after viral inoculation. Left ventricular wall thickness and the diameter of ventricular myocytes also were greater in IL-6 TG than WT after viral infection. Primary cultures of neonatal rat cardiac myocyte showed that IL-6 increased ANP and BNP mRNA expression in a dose-responsive fashion. In summary, overexpression of ANP and BNP occurs in the ventricles of IL-6 TG mice, along with increased cardiac weight after infection with EMC virus, and impaired responses in the expression of ANP and BNP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12889519

Source DB:  PubMed          Journal:  Res Commun Mol Pathol Pharmacol        ISSN: 1078-0297


  2 in total

1.  Metformin Inhibits Isoproterenol-induced Cardiac Hypertrophy in Mice.

Authors:  Hye-Na Cha; Jung Hyun Choi; Yong-Woon Kim; Jong-Yeon Kim; Myun-Whan Ahn; So-Young Park
Journal:  Korean J Physiol Pharmacol       Date:  2010-12-31       Impact factor: 2.016

2.  Deficiency of iNOS Does Not Prevent Isoproterenol-induced Cardiac Hypertrophy in Mice.

Authors:  Hye-Na Cha; Geu-Ru Hong; Yong-Woon Kim; Jong-Yeon Kim; Jin-Myoung Dan; So-Young Park
Journal:  Korean J Physiol Pharmacol       Date:  2009-06-30       Impact factor: 2.016

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.